Covid-19: Johnson & Johnson seeks approval to conduct vaccine trials for 12-17 age group
Johnson & Johnson has submitted an application to the central drugs standard control organisation (CDSCO) to conduct a study of its Covid-19 vaccine in India in adolescents aged 12-17 years.
http://dlvr.it/S60NVs
http://dlvr.it/S60NVs
Comments
Post a Comment